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Design: Paired randomized controlled trials.
Setting: Academic.
Patient(s): Infertile couples (N ¼ 192) with female partner%42 years old and normal ovarian reserve.
Intervention(s): Fertilized zygotes from each patient were randomly divided into two groups: [1] cultured in sequential media and [2]
cultured in monophasic medium. Sequential media consisted of Quinn's Advantage Cleavage Medium (SAGE) followed by Blast Assist
(Origio). The monophasic medium used was Continuous Single Culture (Irvine Scientiﬁc). Paired ETs were accomplished by transferring
the best euploid blastocyst from each media group. DNA ﬁngerprinting was used to link outcomes.
Main Outcome Measure(s): The primary outcome measure was the proportion of blastocysts suitable for clinical use. Secondary
outcomemeasures included timing of blastulation, aneuploidy rates, and SIR. Sustained implantation rate is deﬁned as the number fetal
heart beats at 8–9 weeks of gestation, divided by the number of embryos transferred.
Result(s): A total of 192 patients had their 2PN embryos (N¼ 2,257) randomized to each culture system. Sequential media had higher
blastulation rate than monophasic medium (55.2% vs. 46.9%). No differences were found in the day of blastulation or aneuploidy rate.
Of the 168 patients who had euploid blastocysts suitable for transfer, 126 completed a paired ET. Among the double ETs, there was no
difference in implantation between groups.
Conclusion(s): This is the ﬁrst randomized controlled trial to examine paired euploid transfers of sibling zygotes cultured in sequential
versus monophasic media. This study demonstrates that the usable blastocyst rate is greatest after culture in the sequential media tested
in comparison with the monophasic formulation selected for study. However, no difference exists in timing of blastulation, aneuploidy,
or SIR. Whether these observations are generalizable to other media systems remains to be determined.
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T wo widely used but distinct approaches of culture me-dia have emerged to support embryonic growth to theblastocyst stage of development: sequential and mono-
phasic media. Sequential media, otherwise known as the
‘‘back to nature,’’ approach is a two-step formulation de-
signed to accommodate changes in embryo metabolism
before and after the compaction stage of development (1, 2).
In contrast, monophasic formulations are one step and
capable of supporting embryonic growth through all stages
of development. Functionally, monophasic formulations ‘‘let
the embryo choose’’ which nutrients are required whereas
sequential formulations may mimic in vivo conditions more
closely (3, 4). Both culture systems have demonstrated
excellent clinical outcomes. However, at present, there is no
consensus among clinical programs as to which approach is
optimal as evidenced that both systems remain in
widespread clinical use.
The ﬁrst attempts at blastocyst culture used monophasic
formulations, as referenced, but these were replaced by
sequential culture systems, which purported better implanta-
tion rates (5–7). Sequential culture systems reﬂected an
increased understanding of the physiologic requirements of
the growing embryo in vivo (8–11). Step 1 primarily consists
of nonessential amino acids, ethylenediaminetetraacetic acid
(EDTA), pyruvate, and a reduced concentration of glucose to
support before compaction development. In a temporally
correct manner, step 2 removes EDTA, adds essential amino
acids, decreases the concentration of pyruvate and increases
the concentration of glucose to support after compaction
development. Most of the pioneering work in support for
sequential media was performed using animal models that
demonstrated improved fetal development and increased
implantation rates (12–14).
A continued strong interest remained in optimizing
monophasic formulations, as they are simpler to use and
less expensive in practice. Monophasic medium incorporates
all the necessary ingredients for culture to blastocyst stage
including nonessential and essential amino acids, EDTA,
glucose, pyruvate, and lactate in a constant concentration.
Consequently, monophasic medium requires less manipula-
tion of the embryo and fewer resources to support develop-
ment, especially if medium is not renewed on day 3 of
development. The improvement in monophasic culture sys-
tems was rigorously developed in animal model using simplex
optimization (4, 15).
Several sequential and monophasic media formulations
are US Food and Drug Administration approved and commer-
cially available. Ready availability of these high quality cul-
ture media has likely contributed to increased utilization of
blastocyst culture in clinical settings. Some studies suggest
equivalent outcomes in embryological parameters when
tested among sibling zygotes, but are underpowered to assess
differences in implantation and have not yet assessed aneu-
ploidy risk (16–18). At present, there has not been an
adequately powered randomized rigorously controlled trial
to evaluate blastocyst culture in contemporary IVF practice.
The goal of the present analysis is to perform a paired,
prospective randomized controlled trial to assess usable
blastulation rates, aneuploidy risk, and sustained
ORIGINAL ARTICLE: ASSISTED REPRODUCTION1216implantation rates among sibling zygotes cultured in
monophasic compared with sequential media. For the
purposes of this analysis the sequential media tested
consisted of Quinn's Advantage Cleavage Medium (SAGE)
followed by Blast Assist (Origio). The monophasic media
used was Continuous Single Culture (Irvine Scientiﬁc).MATERIALS AND METHODS
Patient Population
Infertile couples attempting conception through IVF at a sin-
gle center from August 2013 to March 2015 were evaluated to
determine study eligibility. Given the paired design where
each patient served as her own control, it was critical to re-
cruit patients who met the American Society for Reproductive
Medicine guidelines for having two (or more) embryos trans-
ferred (19). All study participants had also elected to use
comprehensive chromosomal screening to assess for embry-
onic aneuploidy.
Inclusion criteria reﬂected the paired nature of the study
design and targeted patients with normal ovarian reserve,
therefore each patient would serve as her own control. Patients
%42 years old at the time of IVF cycle were eligible for inclu-
sion if the FSH level was <12 IU/L, AMH R1.2 ng/mL, and
basal antral follicle countR12. To exclude confounding vari-
ables, patients with the following characteristics were not
offered enrollment [1] chronic endometrial insufﬁciency, [2]
use of oocyte donation or gestational carriers, [3] medical
contraindication to double embryo transfer or IVF, [4] severe
male factor infertility requiring surgical sperm extraction, or
[5] single gene disorders.
The protocol was Institutional Review Board approved
and registered with clinicaltrials.gov (NCT01917240). All pa-
tients that met inclusion criteria and expressed the desire to
participate in the study were consented before ovarian
stimulation.IVF Cycle Management
There were no restrictions on stimulation protocols as the
study intervention began after fertilization was conﬁrmed.
Due to the paired nature of the study design every patient
had their zygotes randomized to sequential and monophasic
media. This design allowed for a comparison of zygotes
exposed to identical endocrine milieus during follicular stim-
ulation, thereby eliminating confounding variables associ-
ated with follicular stimulation.
Standard regimens for controlled ovarian hyperstimula-
tion (COH) were employed using puriﬁed urinary FSH or re-
combinant FSH and LH activity in the form of low-dose
hCG or hMG along with GnRH agonist (long down-
regulation or microdose ﬂare) or GnRH antagonist to prevent
a premature LH surge. Monitoring of IVF cycles were per prac-
tice routine. Oocyte maturation was induced with recombi-
nant hCG, puriﬁed urinary hCG, or with GnRH agonist. This
was performed when at least two follicles reached 17–
18 mm or when the follicular cohort was deemed to be mature
by the patient's primary physician. Transvaginal oocyte aspi-
ration was performed approximately 36 hours later. CumulusVOL. 105 NO. 5 / MAY 2016
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cytes was performed by intracytoplasmic sperm injection
(ICSI).Randomization and Blastocyst Selection
The study was designed to provide a paired comparison of two
embryonic culture systems on in vitro embryo development.
To achieve this paired design, each patient's cohort of fertil-
ized zygotes was split into two dishes of equivalent number
and labeled ‘‘A’’ or ‘‘B.’’ The embryologist then opened an en-
velope designating which media system group A and group B
was to be cultured in (Fig. 1). This experimental design has
been used successfully in multiple prior studies involving
the clinical assisted reproductive technology (ART) labora-
tories (20–23). Allocation concealment was achieved using
sequentially numbered, opaque, sealed envelopes. Dishes
were placed into their respective incubators immediately
after conﬁrmation of fertilization.
On day 5 of in vitro culture, embryos from both groups
were assessed. Given that the dishes were coming from in-
cubators with different CO2 concentrations, it was not
possible to blind the embryologist grading and selecting
embryos for transfer as to which culture system had been
used for a given group of embryos. For any given case,
one embryologist evaluated the entire cohort of embryosFIGURE 1
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VOL. 105 NO. 5 / MAY 2016for that single patient, including embryos grown in
sequential and monophasic media. Morphological selection
was a based on a modiﬁed Gardner criteria that examined
the appearance of the inner cell mass (ICM) and trophecto-
derm. All embryos underwent assisted hatching on day 3 of
development, which in the experience of the laboratory
team allows hatching at the time of expansion and typi-
cally earlier than would be seen in unhatched embryos. As-
sisted hatching was performed in <2 minutes for each
culture dish, to minimize any ﬂuctuations in pH or
temperature.
All fair and good quality expanded blastocysts underwent
trophectoderm biopsy and comprehensive chromosome
screening (24). Aneuploidy screening results were available
the following morning (day 6 of development). At that time
the euploid blastocyst with the best morphological develop-
ment was selected from each group. These two embryos were
then transferred. All patients and physicians were blinded to
the results.
All patients met American Society for Reproductive Med-
icine criteria for a double blastocyst transfer and had already
designated their preference for a double-ET before study partic-
ipation. As such, no patients had additional risk for multiple
gestation based on their participation in the study. In spite of
this, all patients were thoroughly counseled before study
enrollment about the risk of multiple gestation.Viable blast 
biopsy
CCS
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groups and cultured in sequential or monophasic media. Embryological
ere compared. CCS ¼ comprehensive chromosome screening; ICSI ¼
1217
ORIGINAL ARTICLE: ASSISTED REPRODUCTIONPatients at risk for ovarian hyperstimulation syndrome
(OHSS) or who did not have expanded blastocysts until day
6 of development underwent a frozen double-ET of one
euploid blastocyst from each media group. Patients with
euploid embryos from only one culture condition received a
single-ET. Pregnancies were observed until delivery, after
which a DNA ﬁngerprinting assay was done to determine
the culture group from which the delivery originated (Fig. 1).Laboratory Intervention
Tri-gas incubators (Panasonic model MCO-5M-PA) were used
for this study. An oxygen tension of 5% was used in all incu-
bators. A group of incubators were dedicated to the study, half
of which were calibrated for culture in sequential media and
the other half for monophasic medium. The CO2 and temper-
ature of each incubator was measured and recorded every
morning at the same time. The pH was measured in each incu-
bator on a weekly basis, and the CO2 gas level was adjusted to
maintain the pH within the range found to be optimal for
blastulation in the laboratory and this value differed for the
two types of media. The optimal pH for monophasic medium
was 7.31 and for sequential media, it was slightly more acidic
for precompaction development (7.25–7.28) and slightly more
alkaline (7.35–7.38) for postcompaction development.
Sequential media consisted of Quinn's Advantage Cleavage
Medium (SAGE) followed by Blast Assist (Origio). The mono-
phasic media used was Continuous Single Culture (Irvine
Scientiﬁc).
Laboratory management of each case was broken into
three phases. The ﬁrst phase extended from isolation of the
oocyte-cumulus complexes from the aspirated follicular ﬂuid
(FF) to the completion of ICSI and conﬁrmation of fertiliza-
tion. These procedures were performed per routine laboratory
protocol and were identical for both groups.
The second phase represented the experimental phase. Af-
ter conﬁrmation of fertilization, the zygotes were transferred
to dishes that had been pre-equilibrated with either sequential
or monophasic media. Embryos grown in sequential media
were moved on day 3 from phase I to phase II medium as per
laboratory routine. Media was not renewed for embryos cul-
ture in monophasic medium. The embryos from both groups
were hatched on day 3 as per routine in the laboratory for em-
bryos planned to undergo preimplantation genetic screening.
The third phase was embryo development to the
expanded blastocyst stage followed by trophectoderm biopsy.
All supernumerary blastocysts were vitriﬁed.Statistical Analysis
The primary outcome was the proportion of zygotes with two
pronuclei (2PN) that developed into expanded blastocysts
suitable for clinical use (either transfer or cryopreservation,
with a modiﬁed score 3CC or better). These morphologically
normal embryos were termed usable blastocysts. This measure
of in vitro development is the end point of choice when
comparing laboratory outcomes and is the parameter by
which quality assurance and quality control activities are per-
formed in this laboratory.1218Secondary outcomes included timing of blastulation and
ploidy status. Timing of blastulation was deemed ‘‘on time’’ if
an embryo blastulated before the afternoon of day 5
(120 hours after ICSI) and deemed ‘‘late’’ if the embryo did
not become an expanded blastocyst until the morning of
day 6. Finally, sustained implantation, as deﬁned by the pres-
ence of a fetal heart beat after 9 weeks gestation, was
compared between groups.
Paired analyses were performed. The Wilcoxon signed-
rank test was used to compare paired rates of embryological
development. McNemar's c2 for concurrence was used to
compare sustained implantation rates for those patients un-
dergoing paired ET. Pearson's c2 was used to compare sus-
tained implantation rates for all transferred embryos.
Parameters of in vitro development were reported ﬁrst as
an overall effect on all embryos in aggregate, and then sec-
ondly in a paired fashion. Table 1 reports the overall mean
of these rates.
RESULTS
One hundred ninety eight patients were enrolled and the pop-
ulation reﬂected inclusion criteria with an average age
34.3 years old, average day 3 FSH level of 6.6 IU/L, AMH
value of 4.2 ng/mL, and 12  5.4 fertilized zygotes. Six pa-
tients withdrew from study protocol after consent, ﬁve for
personal reasons not related to study design and one for me-
dia that failed to pre-equilibrate. This resulted in 192 patients
whose zygotes underwent randomization for growth in either
sequential or monophasic media. After ICSI, 2,257 of the
2,543 metaphase II were fertilized (88.8% fertilization rate).
Patients (192) completed the study protocol through blasto-
cysts development; however, an additional six patients with-
drew from the study at this point and did not complete an ET,
with explanations ranging from natural conception (1 pa-
tient), marital issues (1), desire for sex selection (2), or embryo
banking (2 patients). Eleven patients had no ET due to com-
plete embryonic arrest, and seven patients had no ET as all
embryos were aneuploid. This resulted in 168 patients who
completed the study protocol, including ET. No patients
were lost to follow-up and all pregnancy outcomes were
available. Throughout the study, the culture systems per-
formed as planned, passing regular quality assurance with
pH optimized as described.Overall In Vitro Development
A total of 2,257 zygotes were randomly assigned to each cul-
ture system—1,127 to monophasic medium and 1,130 to
sequential media. One thousand one hundred ﬁfty zygotes
formed usable blastocysts, yielding an overall blastocyst con-
version rate of 51.0% (monophasic medium 46.9% [528/
1,127] and sequential media, 55.2% [622/1,130]) (Table 1).
These proportions are consistent with results typically at-
tained in this embryology laboratory.
Comprehensive chromosomal screening was performed
for all usable blastocysts and 802 were deemed euploid. Of us-
able blastocysts, 69.1% (365/528) resulted from monophasic
culture and 70.3% (437/622) from sequential media. Of the re-
maining embryos, 9 resulted as nonconcurrent where theVOL. 105 NO. 5 / MAY 2016
TABLE 1
In vitro development: sequential media yielded more usable blastocysts per patient.
Parameter Sequential Monophasic P value
2PNs 1,130 1,127
No. of usable blastocycts (rate) 622 (55.2%) 528 (46.9%) .0001
No. of euploid (rate, expressed per no. of usable blastocysts) 437 (70.3%) 365 (69.1%) .5518
No. of usable euploid blastocysts (transferred and cryopreserved)
(rate expressed per no. of 2PNs)
437 (38.7%) 365 (32.4%) .0018
Note: PN ¼ pronuclei.
Werner. Two-step medium yields more blastocysts. Fertil Steril 2016.
Fertility and Sterility®consistency of data within each of the 24 chromosomes was
insufﬁcient to determine ploidy status, 1 sample failed to
amplify, and the rest of the embryos were aneuploid.Paired Analysis of In Vitro Development
A paired analysis was then performed within each patient
(N ¼ 192) to determine whether the type of culture media
impacted embryo development. Ninety seven (50.5%) patients
were more likely to have embryos form usable blastocysts in
sequential media. This is in comparison with the 61 (31.8%)
patients who had more usable blastocysts in monophasic
and 34 (17.7%) patients where culture media made no differ-
ence (Fig. 2). For the study population, sequential media was
statistically more likely to result in more usable blastocysts in
comparison tomonophasic medium (P¼ .0001). It follows that
the number of usable euploid blastocysts was also higher in
embryos cultured in the chosen sequential media in compar-
ison with the selected monophasic medium (P¼ .0018)
(Table 1).
This type of analysis was then performed in patients who
formed at least one usable blastocyst in each group (N ¼ 154)
to determine whether embryos grown in sequential media
were more likely to blastulate ‘‘on time’’ in comparison with
embryos grown in monophasic medium. There was no statis-FIGURE 2
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VOL. 105 NO. 5 / MAY 2016tical difference per patient in the time to blastulation regard-
less of culture media (P¼ .4063). Similarly this analysis was
performed to determine the euploid rate of usable blastocysts
per patient and no statistical difference was noted regardless
of culture media (P¼ .5518).Paired Analysis of Reproductive Competence
among Transferred Euploid Blastocysts
Pregnancy rates (PR) of the transferred blastocysts in the
group of patients undergoing planned double-ET (one from
each of the culture groups, N ¼ 126) were analyzed. From
this group, 60 patients sustained implantation of both em-
bryos resulting in twins, 36 patients had implantation of
only one embryo and had a singleton gestation, and 30 pa-
tients did not become pregnant.
All double-ETs that resulted in singleton gestations un-
derwent DNA ﬁngerprinting to determine whether the embryo
from sequential or monophasic culture media sustained im-
plantation. Of these no statistical difference was noted in sus-
tained implantation as 19 resulted from culture in sequential
media and 17 resulted from culture in monophasic medium
(P¼ .868) (Table 2).
An analysis was then performed of patients undergoing
only a single ET (n ¼ 42). Single ETs were only performed if
a patient only had one usable euploid blastocyst from one cul-
ture group. Twenty-one single ETs resulted in sustained im-
plantation, 12 from sequential media and 9 from transfer in
monophasic culture. The remaining single ETs did not result
in pregnancy, 12 from sequential and 9 frommonophasic cul-
ture. There was no statistical difference in implantation when
comparing media to support blastocyst development in pa-
tients completing a single ET (P¼1.0). This study had an
80% power to detect a 15% difference in implantation rates.
DISCUSSION
This study systematically demonstrates that culture in the
monophasic medium selected for study (Continuous Single
Culture, Irvine Scientiﬁc) results in a lower usable blastocyst
formation rate when compared with the tested sequential me-
dia ((Quinn's Advantage Cleavage Medium, SAGE) followed
by Blast Assist (Origio)). There were no signiﬁcant differences
identiﬁed in the timing of blastulation or ploidy rates. This
suggests that patients will have more usable euploid blasto-
cysts when grown in the chosen sequential media likely al-
lowing each patient a greater cumulative opportunity for ET1219
TABLE 2
Euploid ET(s): sustained implantation rates were similar between the two culture groups.
Characteristic Total no. of patients Total no. of embryos
Sustained implantation rate in
sequential media
Sustained implantation rate in
monophasic media P value
ET completed 168
Paired 126 252 19/36 17/36 .868
Single ET 42 42 12/24 9/18 1.0
Werner. Two-step medium yields more blastocysts. Fertil Steril 2016.
ORIGINAL ARTICLE: ASSISTED REPRODUCTIONand pregnancy. However, the type of media did not impact the
reproductive potential of those embryos that did blastulate.
Once a euploid blastocyst was of sufﬁcient quality to be
selected transfer, sustained implantation rates were equiva-
lent for sequential and monophasic media. This is the ﬁrst
paired randomized controlled trial to assess differences in
blastulation rates between sequential and monophasic media.
These ﬁndings differ from results proposed by earlier
studies, which suggested that monophasic media formula-
tions may be better or at least equivalent to sequential media
(16, 17, 25). It is possible that different system-speciﬁc pa-
rameters, including the number of embryos in group culture,
the incubators used, and laboratory-speciﬁc characteristics,
may not be confounding variables given the paired experi-
mental design used in this study (26). Although monophasic
media formulations are based on the same principles of devel-
opment, they may differ widely in the physical concentration
of substrates and as such the results presented may not be
generalizable to all commercially available formulations.
The ‘‘quiet embryo hypothesis’’ would suggest use of a
monophasic culture system to lessen manipulation of the em-
bryo and achieve superior results, however it seems the ‘‘back
to nature’’ approach may offer patients a greater opportunity
for ET and pregnancy (1, 2). Monophasic formulations have
the advantage of using one system over the entirety of
embryo development, precluding the need for media
renewal on day 3 of development or any assessment that
could expose an embryo to ﬂuctuating environmental
changes (pH, temperature). In addition, monophasic
formulations can be used in conjunction with noninvasive
imaging modalities. Furthermore, monophasic formulations
are cheaper to use as they require less quality assurance and
control testing, fewer resources, and less media (if not
renewed on day 3). Sequential formulations tend to be more
expensive and do require a media switch on day 3 of
development. Although the procedural advantages of
monophasic formulations may be advantageous, the results
of this study demonstrate that sequential media may afford
better clinical outcomes.
The major strengths of the present analysis are the power
of the paired zygote design and selection of only euploid em-
bryos for transfer. Whereas meiotic errors should be equiva-
lent in the two groups given that randomization occurred
after the completion of meiosis, there was potential to detect
a difference in mitotic errors. Mitotic errors contribute mean-
ingfully to aneuploidy in human embryos (27). Although a
single biopsy is certainly insufﬁcient to quantitate the abso-
lute level of mosaicism resulting from mitotic errors, it does1220provide a sampling of errors. Given that the meiotic errors
should be equivalent after randomization, any differences
in aneuploidy rates would then obligately reﬂect the propor-
tional difference in the mitotic error rate. The fact that the
overall aneuploidy rates were equivalent indicates that the
choice of media systems does not meaningfully impact on
mitotic error rates during culture. Given the major role that
aneuploidy plays in limiting embryonic reproductive compe-
tence, this ﬁnding is quite reassuring.
Patient inclusion criteria were both a strength and limita-
tion of the study design as only patients with normal ovarian
reserve were analyzed. This allowed for the power to assess
differences in embryological parameters and assess differ-
ences in implantation rates but may prevent applicability to
all patients undergoing IVF cycles. Caution should be used
in applying these ﬁndings to all patient groups and in partic-
ular those who are low responders. Although it would need to
be demonstrated using a rigorous experimental design, it re-
mains possible that intrinsic differences in the oocytes from
low responders might favor a different media formulation
than that which is optimal in normal responders.
One of the most signiﬁcant beneﬁts to monophasic cul-
ture is that the embryo remains undisturbed at the cleavage
stage, diminishing the need for additional dishes, renewal of
media, and dedicated laboratory time and for these reasons
the monophasic medium chosen for this study (Continuous
Single Culture) was not renewed. Similarly assisted hatching
was performed at the cleavage stage on all embryos, as such
the effects of the laser on the monophasic culture medium
cannot be determined. It should be noted that embryos in
sequential culture were both hatched on day 3 and moved
into blast medium (phase 2 medium). This second phase of
sequential medium would have had less exposure to shifts
in temperature and pH then the monophasic formulation.
Although great care was taken in study design, differ-
ences still remained in embryo handling between the two
study arms that may have resulted in a potential confound-
ing variable. It is unknown whether our ﬁndings would be
replicated if embryo handing had been identical in both cul-
ture systems. Due to the nature of this design it was not
possible to blind the embryologists to media as they were
responsible for grading and selection. A necessary next
step would be to investigate whether renewing media at
the cleavage stage may equalize outcomes between groups;
however, this may temper the work-ﬂow and economic ben-
eﬁts gained with using a one-step culture system. In conclu-
sion, these data demonstrate that the sequential media
formulation tested in this study provided superior efﬁciencyVOL. 105 NO. 5 / MAY 2016
Fertility and Sterility®in supporting production of high quality blastocysts suitable
for either transfer or cryopreservation.
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